Management Team

Franco Stevanato resumed his role as Chief Executive Officer of Stevanato Group in May 2024. He previously served as Executive Chairman of the Board and led the Group as CEO from 2010 to 2020.
Franco is responsible for leading the company's global expansion, as well as the transformation of its core strategic objectives, and unique value proposition as an integrated solutions provider to pharma and biotech.
Under his guidance, he led the Group to consistent growth underscored by its primary business pillars - biopharmaceutical and diagnostic solutions, engineering equipment, and analytical services - driving growth from €143 million in revenue in 2010 to over €1.1 billion in 2024.
Before joining Stevanato Group, Franco began his career in sales at Saint-Gobain in France. He holds a bachelor's degree in political science from the University of Trieste and completed the advanced management program at the Kellogg School of Management at Northwestern University.

Marco Dal Lago brings over 25 years of experience in controlling, finance, administration, compliance, IT, and risk management in multinational industrial companies, coordinating multi-year planning, mergers and acquisitions, and IPO processes. Marco joined Stevanato Group in 2020 as the Company’s Chief Financial Officer, where he leads the global finance, controlling, tax, information technology, legal, and administrative teams.
Prior to joining Stevanato Group, Marco served as CFO of Gruppo Mastrotto, the largest leather manufacturer in Europe, with 13 plants worldwide. He spent more than 15 years with Nidec ASI S.p.A. in a variety of executive financial management positions, including group CFO.
He graduated with a bachelor’s degree in business administration from Ca’ Foscari University of Venice, and he successfully completed the advanced management program at MIT in Boston in July.

With more than 25 years of extensive business development experience, Mauro Stocchi joined Stevanato Group in 2004 and has held a variety of key management positions throughout his tenure, including Corporate General Manager and Chief Financial Officer.
Mauro currently serves as Stevanato Group's Chief Business Strategy Officer, where he oversees all strategic business development activities, including sales, product management, corporate development, strategic marketing, and supply chain management.
He previously spent a decade with Siemens Group, and prior to that, he commenced his career at De Longhi S.p.A. Mauro earned a master’s degree in business administration from SDA Bocconi in Milan and holds a bachelor’s degree from Ca’ Foscari University of Venice.

With more than 25 years of experience, Lisa Miles joined Stevanato Group in 2021 as Senior Vice President of Investor Relations and then assumed the role of Chief Communications and Investor Relations Officer in 2024. Lisa currently is responsible for the Group’s global communications, media, and brand strategy, as well as the investor relations function.
Previously, Lisa spent 18 years at Maximus in various management positions. In her most recent role, she served as Senior Vice President of Investor Relations & Corporate Communications for nearly a decade where she was responsible for investor relations, global marketing and branding, media relations, and employee communications.
Named to the 2017 and 2018 Institutional Investor’s All America Executive Team for Midcap Investor Relations, Lisa was ranked third for Best Midcap IR Professionals in the Business, Education, and Professional Services sector. She holds a bachelor’s degree in communications from The Pennsylvania State University and successfully completed an executive leadership program in management and negotiation at the Harvard Business School.

Carla Costa joined Stevanato Group in 2024 as the Senior Director, Corporate Human Resources, and in April 2025, she was appointed as Chief Human Resources Officer, where she leads the Group’s global human resources strategy.
With more than 20 years of industry experience, Carla is a seasoned HR leader with extensive global expertise in leadership development, talent management, and cultural change within complex multinational organizations. She has held strategic roles across multiple industries and geographies, implementing people strategies that drive business success.
Carla began her career as a consultant at Personnel Decision International (PDI) before joining Eli Lilly, where she held various HR roles across Italy, Europe, Latin America, and Shanghai. She later moved to Vodafone, leading initiatives to drive a customer-focused mindset transformation. More recently, she spent a decade contributing to the turnaround of a major European insurance company, overseeing key HR processes to support business growth and transformation.
She holds a degree in organizational psychology from the Università Cattolica of Milan and multiple certifications in leadership assessment and coaching.

Ugo Gay brings more than 30 years of international management experience in the pharmaceutical and diagnostics industries. He joined Stevanato Group in 2024 as Chief Operations Officer. More recently, in 2025, he was appointed President of the Drug Containment Solutions Business Unit and Shared Services where he leads the Group’s operational and growth strategy.
Ugo began his career in 1995 at the Istituto Biologico Chemioterapico in Turin, where he became CEO of a subsidiary in 1998. In 2000, he joined Diasorin as Sales Director for the Italian market, where he held various leadership roles during his tenure, including Vice President on the Board of Assobiomedica and the European Diagnostic Manufacturers Association (EDMA). In 2012, he transitioned to Diasorin's Industrial Operations Group (EMEA) and was appointed Senior Vice President of Corporate Industrial Operations in 2019. Following the spin-off of a business unit in 2022, he became CEO and General Manager of the new subsidiary, Diasorin Italia S.p.A. He holds a degree from the SDA Bocconi School of Management in Milan.

Raffaele Pace joined Stevanato Group in 2020 as Vice President, Operations for the Engineering Segment. In 2025, Raffaele was appointed President of the Engineering Business Unit, assuming global responsibility for operations, technological innovation, and industrial strategy across the unit’s product lines, including glass converting, sterile packaging, drug delivery system - sub and final assembly, secondary packaging, and visual inspection.
Raffaele brings over 20 years of international experience in the engineering, packaging, and pharmaceutical sectors. He has held leadership roles in R&D, product management, operations, and innovation, with P&L accountability and extensive experience in driving growth, efficiency, and business transformation in complex global environments.
Before joining Stevanato Group, he served as Vice President of Product Management & Digital Solutions at Sidel. Raffaele holds a master’s degree in mechanical engineering and an MBA from Bologna Business School.

Michele Monico brings more than 25 years of international experience in design and engineering and marketing in the high-tech sector, having led globally distributed teams in highly regulated industries such as medical devices and drug delivery systems. Following a two-year period as Vice President of the Drug Delivery Systems business line at Stevanato Group, Michele was appointed President of the DDS and IVD Business Unit in July 2025.
Before joining Stevanato Group, Michele served as Senior Vice President of Global Design at Star, a strategic management and technology consulting company headquartered in the Silicon Valley. During his tenure, he also served in a variety of managerial roles at Flex within the Health Solutions and Medical Business Unit, as well as at INPECO.